#United States #Washington #Research Grants #Lung Cancer #LUNGevity

LUNGevity Foundation Accepts 2026 Research Grant Applications

In an effort to advance the fight against lung cancer, the LUNGevity Foundation, recognized as the leading nonprofit organization dedicated to lung cancer awareness, has begun accepting applications for its 2026 research grants. This initiative aims to promote groundbreaking discoveries in lung cancer by funding innovative research projects that can improve early detection, treatment strategies, and health equity for patients.

Funding for Change

Since its inception in 2002, LUNGevity has supported over 200 lung cancer research projects, allocating more than $55 million to propel essential discoveries in the field. Upal Basu Roy, PhD, MPH, the Executive Director of LUNGevity Research, expressed the organization’s commitment to transforming outcomes for those diagnosed with lung cancer in the face of increasingly challenging funding environments. "Every year we meticulously design award programs that address the most pressing issues affecting lung cancer patients," he stated.

The research grants available this year will empower a new generation of lung cancer researchers. The foundation crafted several programs designed to build a robust pipeline of innovative ideas and targeted solutions for lung cancer diagnosis and treatment.

Award Programs Overview

LUNGevity is offering several key funding opportunities:

1. Career Development Award: This flagship program is geared towards fostering future leaders in lung cancer research. Funded projects will have a significant impact on either the early detection of lung cancer or improving patient outcomes. This three-year grant is valued at $300,000. Interested applicants must submit a letter of intent by February 17, 2026.

2. Health Equity and Inclusiveness Research Fellow Award: Aiming to support underrepresented minorities in STEM, this award extends $100,000 over two years. Eligible applicants must hold a doctoral degree and be pursuing postdoctoral research focused on lung cancer. The letter of intent deadline aligns with the Career Development Award on February 17, 2026.

3. VA Research Scholar Award: This program targets investigators working within the Veterans Affairs system. Applicants must have a doctoral degree, and can be current postdoctoral fellows or junior faculty members. This award also offers $100,000 over two years with the same intent letter due date.

4. ASTRO-LUNGevity Residents/Fellows in Radiation Oncology Seed Grant: Designed to support residents and fellows who are keen on radiation oncology research related to lung cancer, this one-year grant provides $50,000, with submissions due by January 26, 2026.

Importance of Research in Lung Cancer

The move towards enhancing research funding comes at a crucial time, particularly given the staggering lung cancer statistics in the United States. Approximately 1 in 18 Americans will receive a lung cancer diagnosis in their lifetime, reflecting an urgent need for improved detection and treatment methods.

LUNGevity aims not only to advance the scientific understanding of lung cancer but also to improve health equity across patient demographics. By tackling disparities within the healthcare system, the foundation works toward ensuring every individual has access to life-saving screening and treatment options.

Looking Ahead

Award recipients for the 2026 grants are anticipated to be announced in late summer 2026. The long-term vision of LUNGevity remains crystal clear—a world where no one succumbs to lung cancer. Community education, advocacy initiatives, and a range of patient-centric resources are all part of this mission.

For further details on how to apply for these crucial research grants, interested parties can visit the LUNGevity website. Together, we can pave the way for innovative solutions and improved outcomes for lung cancer patients nationwide.